1. Netherlands Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Redcare Pharmacy N.V.

Redcare Pharmacy N.V.

SHPPF
Redcare Pharmacy N.V.US flagOther OTC
64.80
USD
- -
- -
1.30BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
6.1
9.34
13.85
19.56
29.9
44.8
53.66
67.32
59.29
66.96
93.5
118.21
146.25
152.8
Basic EPS, GAAP
-0.31
-0.56
-1.16
-2.03
-2.25
-2.79
-2.78
-1.17
-4.15
-4.32
-0.63
-2.27
-1.87
-1.86
Free Cash Flow per Basic Share
-0.97
-0.66
-1.41
-2.33
-3.46
-2.19
-3.48
-2.47
-1.76
-4.59
1.21
-1
-4.36
-5.09
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
-1.15
0.02
30.46
0.02
0.02
0.02
-11.6
-15.85
-14.49
-16.15
-17.79
37.59
Tangible Book Value per Share
0.71
0.85
-1.23
7.84
5.49
1.17
2.52
15.33
8.83
3.65
6.44
4.92
4.26
3.9
Basic Weighted Avg Shares
9
9
9
9
9
12
13
14
18
18
19
20
20
20
Sales/Revenue/Turnover
55
85
126
177
284
540
701
968
1,060
1,204
1,799
2,371
2,941
3,073
Operating Margin (%)
-4.61
-5.88
-8.07
-7.8
-7.82
-5.36
-4.88
-0.1
-6.21
-5.76
-0.96
-1.65
-1.01
-0.78
Depreciation Expense
1
2
2
3
7
13
15
16
27
40
57
68
69
70
Net Income, GAAP
-3
-5
-11
-18
-21
-34
-36
-17
-74
-78
-12
-46
-38
-37
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-5.12
-5.95
-8.4
-10.4
-7.52
-6.23
-5.17
-1.73
-7
-6.45
-0.67
-1.92
-1.28
-1.22
Working Capital
5
6
11
75
54
83
151
179
309
225
276
250
219
204
LT Debt
- -
- -
19
- -
4
72
132
33
230
248
236
237
329
332
Total Equity
18
20
2
93
239
214
233
425
415
355
552
510
479
468
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
-14.76
-23.21
-14,223.53
-5,383.95
- -
- -
- -
- -
- -
-4.95

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
88
86
23
LT Borrowings
- -
262
- -
LT Finance Leases
- -
67
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
1,615
1,284
786

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
636
619
579
Cash, Cash Equivalents & STI
271
203
135
Accounts Receivable, Net
123
130
156
Inventories
171
214
215
Total Current Liabilities
378
400
375
Payables & Accruals
- -
- -
- -
ST Debt
88
86
23
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
395.43%
5.02%
-6.04%
Free Cash Flow
32.57%
34.93%
338%
Net Income, GAAP
62.54%
104.65%
-17.14%
Sales/Revenue/Turnover
38.77%
25.66%
24.06%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
560
561
575
675
2,371
2025
717
709
719
795
2,941
2026
850
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.39
- -
- -
- -
-2.27
2025
-0.54
- -
- -
- -
-1.87
2026
-0.52
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Olaf Heinrich
Full Time Employees
1,827
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Address
Erik de Rodeweg 11–13 Sevenum LI Netherlands 5975 WD
IPO Date
Jan 6, 2021
Website
redcare-pharmacy.com
Similar Companies
Invitae Corporation (0JDB.L)
Auro Laboratories Limited (AUROLAB.BO)
Luyan Pharma Co.,Ltd. (002788.SZ)
CymaBay Therapeutics, Inc. (0I5P.L)
Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
Emmessar Biotech & Nutrition Limited (EMMESSA.BO)
Business
Redcare Pharmacy N.V. (SHPPF) operates as a leading European online pharmacy, offering prescription and non-prescription over-the-counter pharmaceuticals; beauty and personal care products; nutritional supplements and food supplements; and health-related products through webshops and digital services. The company serves over 10 million active customers across Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands with more than 150,000 products, including brands such as shop-apotheke.com, shop-apotheke.at, Redcare.it, Redcare-apotheke.ch, Redcare-pharmacie.fr, farmaline.nl, farmaline.be, smartpatient.eu, medapp.nl, and gopuls.de; it provides specialized services like medication management apps (MyTherapy and medapp), instant delivery within half an hour in Germany, prescription drug delivery in select markets, and the CardLink solution for electronic prescriptions. Founded in 2001 and headquartered in Sevenum, Netherlands, Redcare Pharmacy emphasizes a people-first approach with digital healthcare innovations and sustainability aligned to the Paris Climate Agreement. In spring 2023, the company completed a strategic partnership with Galenica involving MediService to create Switzerland's leading online pharmacy, integrating offerings at mediservice.ch and redcare-apotheke.ch. Redcare Pharmacy changed its name from Shop Apotheke Europe N.V. to Redcare Pharmacy N.V. in June 2023, unifying its brand across markets while retaining local identities. Recent developments include the extension of its CardLink solution by gematik in July 2025, confirmation of a Rx bonus for EU mail order pharmacies by German courts in July 2025, announcement of CFO Jasper Eenhorst stepping down in September 2025, sustained sales growth with total sales up 26.4% to EUR 709 million in Q2 2025 and 32% to EUR 2.4 billion for full-year 2024, and reaffirmed full-year 2025 guidance following strong Q3 performance in October 2025.

Company News

APIChatGPT

  • defenseworld.net

    Redcare Pharmacy (OTC:SHPPF) Stock Price Down 0.3% – Here’s What Happened

  • reuters.com

    German online drug retailer Redcare Pharmacy names Hendrik Krampe as CFO

  • businesswire.com

    CTP Builds 30,000 sqm of Distribution Space for Redcare Pharmacy, Europe's Leading Online Pharmacy

  • seekingalpha.com

    Redcare Pharmacy NV (SAEYY) Q3 2024 Earnings Call Transcript